439 related articles for article (PubMed ID: 18657652)
1. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group.
Steiner G; Pauly NC
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S81-5. PubMed ID: 7527108
[TBL] [Abstract][Full Text] [Related]
4. Reduced total mortality and death from myocardial infarction and stroke in moderate/severe hypertensives treated with "Tenormin" (atenolol).
Cruickshank JM
Drugs Exp Clin Res; 1990; 16(3):133-6. PubMed ID: 2387213
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
Verdecchia P
Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
[TBL] [Abstract][Full Text] [Related]
6. Treatment of angina pectoris and hypertension with sustained-release calcium channel-blocking drugs.
Klein MD; Weiner DA
Circulation; 1987 Jun; 75(6 Pt 2):V110-3. PubMed ID: 3552310
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy and myocardial infarction: focus on calcium antagonists.
Bühler FR; Müller FB; Linder L; Bolli P
J Hypertens Suppl; 1985 Nov; 3(2):S95-8. PubMed ID: 2868083
[TBL] [Abstract][Full Text] [Related]
8. Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.
Sharma SK; Ruggenenti P; Remuzzi G
Vasc Health Risk Manag; 2007; 3(4):453-65. PubMed ID: 17969376
[TBL] [Abstract][Full Text] [Related]
9. The Beta-Blocker Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients. The Beta-Blocker Pooling Project Research Group.
Eur Heart J; 1988 Jan; 9(1):8-16. PubMed ID: 2894312
[TBL] [Abstract][Full Text] [Related]
10. Smoking, antihypertensive treatment benefit, and comprehensive antihypertensive treatment approach: some thoughts on the results of the International Prospective Primary Prevention Study in Hypertension.
Bolli P; Bühler FR; McKenzie JK
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S77-80. PubMed ID: 1708033
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerability of antihypertensive treatment based on atenolol in the prevention of stroke and the regression of left ventricular hypertrophy.
Cruickshank JM; Higgins TJ; Pennert K; Thorp JM; Zacharias FM; Zacharias FJ
J Hum Hypertens; 1987 Sep; 1(2):87-93. PubMed ID: 3506623
[TBL] [Abstract][Full Text] [Related]
12. Secondary prevention after myocardial infarction: in favor of beta-blockers.
Lévy S
J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S50-4. PubMed ID: 1707116
[TBL] [Abstract][Full Text] [Related]
13. Beta blockers and quality of life.
Cruikshank JM; McAinsh J
Br J Clin Pract; 1992; 46(1):34-8. PubMed ID: 1358162
[TBL] [Abstract][Full Text] [Related]
14. Verapamil in the long-term treatment of angina pectoris.
Raftos J
Clin Exp Pharmacol Physiol Suppl; 1982; 6():43-9. PubMed ID: 6811176
[TBL] [Abstract][Full Text] [Related]
15. [Calcium antagonists vs ACE inhibitors in the treatment of essential arterial hypertension in the aged].
Cellamare G; Poppa E; Sgobba G; Bianco G
Minerva Cardioangiol; 1989 Mar; 37(3):111-8. PubMed ID: 2546102
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenergic blockers in patients with acute myocardial infarction.
Furberg CD; Byington RP
Cardiovasc Clin; 1989; 20(1):235-48. PubMed ID: 2565768
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-blocker therapy on recurrent nonfatal myocardial infarction.
Furberg CD; Bell RL
Circulation; 1983 Jun; 67(6 Pt 2):I83-5. PubMed ID: 6133649
[TBL] [Abstract][Full Text] [Related]
18. Verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
Eur Heart J; 1984 Jul; 5(7):516-28. PubMed ID: 6383832
[TBL] [Abstract][Full Text] [Related]
19. The place of the calcium antagonist verapamil in antihypertensive therapy.
Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
[TBL] [Abstract][Full Text] [Related]
20. Treatment with verapamil during and after an acute myocardial infarction: a review based on the Danish Verapamil Infarction Trials I and II. The Danish Study Group on Verapamil in Myocardial Infarction.
Hansen JF
J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S20-5. PubMed ID: 1725912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
